Healthcare provider profile · identity verified

Robert J Juhala, MD

Internal Medicine · FORT COLLINS, CO · NPI 1851329973

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1251	360
Lisinopril	Lisinopril	932	256
Levothyroxine Sodium	Levothyroxine Sodium	850	224
Omeprazole	Omeprazole	668	203
Losartan Potassium	Losartan Potassium	654	188
Amlodipine Besylate	Amlodipine Besylate	600	175
Rosuvastatin Calcium	Rosuvastatin Calcium	590	180
Tamsulosin Hcl	Tamsulosin Hcl	420	120
Metoprolol Succinate	Metoprolol Succinate	400	109
Hydrochlorothiazide	Hydrochlorothiazide	349	112
Simvastatin	Simvastatin	287	82
Escitalopram Oxalate	Escitalopram Oxalate	276	83
Trazodone Hcl	Trazodone Hcl	259	85
Metformin Hcl	Metformin Hcl	252	70
Gabapentin	Gabapentin	247	71
Carvedilol	Carvedilol	245	76
Pantoprazole Sodium	Pantoprazole Sodium	229	66
Eliquis	Apixaban	208	57
Tramadol Hcl	Tramadol Hcl	204	67
Alendronate Sodium	Alendronate Sodium	191	58
Furosemide	Furosemide	179	74
Valsartan	Valsartan	163	46
Allopurinol	Allopurinol	160	47
Potassium Chloride	Potassium Chloride	160	47
Montelukast Sodium	Montelukast Sodium	139	47
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	126	49
Ezetimibe	Ezetimibe	125	39
Donepezil Hcl	Donepezil Hcl	124	30
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	121	38
Synthroid	Levothyroxine Sodium	121	31
Bupropion Xl	Bupropion Hcl	117	36
Duloxetine Hcl	Duloxetine Hcl	113	30
Fluoxetine Hcl	Fluoxetine Hcl	111	31
Metformin Hcl Er	Metformin Hcl	110	33
Celecoxib	Celecoxib	107	39
Venlafaxine Hcl Er	Venlafaxine Hcl	103	25
Chlorthalidone	Chlorthalidone	101	33
Albuterol Sulfate Hfa	Albuterol Sulfate	96	46
Clopidogrel	Clopidogrel Bisulfate	96	25
Sertraline Hcl	Sertraline Hcl	95	33
Citalopram Hbr	Citalopram Hydrobromide	94	29
Zolpidem Tartrate	Zolpidem Tartrate	93	55
Pravastatin Sodium	Pravastatin Sodium	89	25
Metoprolol Tartrate	Metoprolol Tartrate	88	24
Spironolactone	Spironolactone	85	24
Finasteride	Finasteride	82	27
Olmesartan Medoxomil	Olmesartan Medoxomil	82	25
Terazosin Hcl	Terazosin Hcl	81	21
Meloxicam	Meloxicam	80	34
Lorazepam	Lorazepam	79	34
Mounjaro	Tirzepatide	76	15
Clonazepam	Clonazepam	74	27
Memantine Hcl	Memantine Hcl	72	19
Buspirone Hcl	Buspirone Hcl	71	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	71	21
Ipratropium Bromide	Ipratropium Bromide	70	30
Quetiapine Fumarate	Quetiapine Fumarate	67	15
Jardiance	Empagliflozin	65	18
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	65	23
Ozempic	Semaglutide	65	14
Glipizide Er	Glipizide	62	22
Pregabalin	Pregabalin	62	28
Pioglitazone Hcl	Pioglitazone Hcl	61	20
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	58	17
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	57	45
Warfarin Sodium	Warfarin Sodium	56	17
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	55	17
Irbesartan	Irbesartan	55	16
Prednisone	Prednisone	53	42
Ropinirole Hcl	Ropinirole Hcl	53	15
Fluticasone Propionate	Fluticasone Propionate	52	18
Paroxetine Hcl	Paroxetine Hcl	49	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	48	18
Methylprednisolone	Methylprednisolone	46	45
Verapamil Er	Verapamil Hcl	46	17
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	45	28
Diclofenac Sodium	Diclofenac Sodium	44	14
Mirtazapine	Mirtazapine	44	14
Valacyclovir	Valacyclovir Hcl	44	26
Benazepril Hcl	Benazepril Hcl	43	13
Doxazosin Mesylate	Doxazosin Mesylate	41	12
Lamotrigine	Lamotrigine	41	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	41	suppressed
Famotidine	Famotidine	40	15
Paxlovid	Nirmatrelvir/Ritonavir	40	40
Colchicine	Colchicine	39	20
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	39	suppressed
Ondansetron Odt	Ondansetron	37	21
Oxycodone Hcl	Oxycodone Hcl	36	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	35	14
Atenolol	Atenolol	35	suppressed
Alprazolam	Alprazolam	34	18
Oxybutynin Chloride Er	Oxybutynin Chloride	34	suppressed
Topiramate	Topiramate	34	suppressed
Naproxen	Naproxen	33	19
Azelastine Hcl	Azelastine Hcl	32	14
Doxycycline Hyclate	Doxycycline Hyclate	32	25
Lovastatin	Lovastatin	32	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	32	16
Trulicity	Dulaglutide	32	suppressed
Tizanidine Hcl	Tizanidine Hcl	31	16
Cephalexin	Cephalexin	30	25
Xarelto	Rivaroxaban	29	suppressed
Estradiol	Estradiol	28	15
Glimepiride	Glimepiride	28	suppressed
Propranolol Hcl	Propranolol Hcl	28	suppressed
Ibandronate Sodium	Ibandronate Sodium	26	11
Testosterone Cypionate	Testosterone Cypionate	26	12
Tramadol Hcl Er	Tramadol Hcl	26	suppressed
Diazepam	Diazepam	25	16
Hydralazine Hcl	Hydralazine Hcl	25	suppressed
Propranolol Hcl Er	Propranolol Hcl	25	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	24	suppressed
Primidone	Primidone	24	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	24	12
Testosterone	Testosterone	24	suppressed
Enalapril Maleate	Enalapril Maleate	23	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	23	suppressed
Azithromycin	Azithromycin	22	22
Fenofibrate	Fenofibrate Nanocrystallized	22	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	22	suppressed
Fenofibrate	Fenofibrate	21	suppressed
Ketoconazole	Ketoconazole	21	12
Levetiracetam	Levetiracetam	21	suppressed
Cefuroxime	Cefuroxime Axetil	20	18
Januvia	Sitagliptin Phosphate	20	suppressed
Ramipril	Ramipril	20	suppressed
Baclofen	Baclofen	19	suppressed
Acyclovir	Acyclovir	18	suppressed
Clonidine Hcl	Clonidine Hcl	18	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	18	suppressed
Farxiga	Dapagliflozin Propanediol	18	suppressed
Klor-Con M20	Potassium Chloride	18	suppressed
Gemfibrozil	Gemfibrozil	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	suppressed
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Budesonide Dr	Budesonide	16	suppressed
Clonidine	Clonidine	16	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	16	suppressed
Lithium Carbonate	Lithium Carbonate	16	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	16	suppressed
Premarin	Estrogens, Conjugated	16	12
Amoxicillin	Amoxicillin	15	suppressed
Clobetasol Propionate	Clobetasol Propionate	15	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Lidocaine	Lidocaine	15	suppressed
Liothyronine Sodium	Liothyronine Sodium	15	suppressed
Arnuity Ellipta	Fluticasone Furoate	14	suppressed
Hydrocortisone	Hydrocortisone	14	suppressed
Minoxidil	Minoxidil	14	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	14	suppressed
Spiriva Handihaler	Tiotropium Bromide	14	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	14	suppressed
Verapamil Sr	Verapamil Hcl	14	suppressed
Nabumetone	Nabumetone	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	13
Nystatin	Nystatin	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	12	suppressed
Sildenafil Citrate	Sildenafil Citrate	12	suppressed
Linzess	Linaclotide	11	suppressed
Mesalamine Er	Mesalamine	11	suppressed
Temazepam	Temazepam	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error